Genprex, Inc

(NASDAQ:GNPX)

Latest On Genprex, Inc (GNPX):

Date/Time Type Description Signal Details
2023-03-08 10:12 ESTNewsGenprex's Gene Therapy: Potential Breakthrough For Diabetes And Lung CancerN/A
2023-02-27 15:06 ESTNewsGenprex to raise $4M in stock offering to a single, healthcare-focused institutional investorN/A
2022-12-14 17:13 ESTNewsGenprex gets safety panel nod to proceed in lung cancer study of ReqorsaN/A
2022-08-15 15:52 ESTNewsGenprex stock rises 13% on safety panel nod to continue trial of Reqorsa/Tagrisso combo for lung cancerN/A
2022-03-31 11:06 ESTNewsGenprex begins patient enrollment in Phase 1/2 trial testing lung cancer therapyN/A
2022-01-27 15:03 ESTNewsPreclinical study suggests potential use of Genprex ONCOPREX in colon cancerN/A
2022-01-04 13:19 ESTNewsGenprex expands oncology pipeline to include small cell lung cancerN/A
2022-01-03 21:02 ESTNewsGenprex wins FDA’s Fast Track Designation for lead assetN/A
2021-11-19 12:55 ESTNewsGenprex: Limited Clinical Data To Justify RiskN/A
2021-07-21 10:08 ESTNewsGenprex initiates early-stage REQORSA lung cancer studyN/A
2021-05-05 16:48 ESTNewsGenprex receives IRB approval for NSCLC gene therapy trial; shares up 4%N/A
2021-04-12 20:24 ESTNewsGenprex's Reqorsa combo shows encouraging activity in lung cancer, shares up 3%N/A
2021-03-14 15:28 ESTNewsTaking A Gander At GenprexN/A
2021-02-02 08:13 ESTNewsGenprex' stock jumps after corporate updateN/A
2021-01-13 14:00 ESTNewsGenprex achieves manufacturing milestone for immunogene therapy for upcoming lung cancer trialsN/A
2020-12-22 20:33 ESTNewsGenprex completes manufacturing scale-up of lung cancer therapyN/A
2020-12-22 20:33 ESTNewsGenprex launches $12M ATM equity offeringN/A
2020-11-26 20:10 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 11:51 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 15:58 ESTFinancialsCompany financials have been released.Neutral
2020-10-16 21:02 ESTNewsGenprex (GNPX) Investor Presentation - SlideshowN/A
2020-09-26 12:54 ESTFinancialsCompany financials have been released.Neutral
2020-09-24 04:42 ESTAnalyst RatingThe Analyst Target Price has decreased from $7.5 to $6.67.Neutral
2020-09-17 05:01 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 08:58 ESTFinancialsCompany financials have been released.Neutral
2020-08-13 08:50 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 01:08 ESTFinancialsCompany financials have been released.Neutral
2020-07-25 00:48 ESTAnalyst RatingThe Analyst Target Price has increased from $6.5 to $7.5.Buy
2020-07-23 17:11 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 08:52 ESTFinancialsCompany financials have been released.Neutral
2020-06-30 00:03 ESTNewsGenprex added to Russell 3000 indexN/A
2020-06-26 08:51 ESTFinancialsCompany financials have been released.Neutral
2020-06-25 13:13 ESTNewsGenprex nabs USAN approval of non-proprietary name for GPX-001N/A
2020-06-12 04:54 ESTFinancialsCompany financials have been released.Neutral
2020-06-02 12:44 ESTEarnings EstimateAn EPS average of $0.25 is estimated for the 2021 year.Buy
2020-06-02 12:44 ESTEarnings EstimateAn EPS average of -$0.09 is estimated for the quarter ending on September 30, 2020.Buy
2020-06-02 12:44 ESTEarnings EstimateAn EPS average of -$0.07 is estimated for the quarter ending on June 30, 2020.Buy
2020-06-02 12:44 ESTAnalyst RatingThe Analyst Target Price has decreased from $8 to $6.5.Neutral
2020-05-27 04:58 ESTFinancialsCompany financials have been released.Neutral
2020-05-20 20:48 ESTFinancialsCompany financials have been released.Neutral
2020-05-08 11:09 ESTNewsGenprex up 39% premarket on Oncoprex IP dealN/A
2020-05-06 05:01 ESTFinancialsCompany financials have been released.Neutral
2020-05-03 08:59 ESTFinancialsCompany financials have been released.Neutral
2020-04-26 00:48 ESTAnalyst RatingThe Analyst Target Price has increased from $5 to $8.Buy
2020-04-11 17:50 ESTNewsGenprex up 29% on license for diabetes gene therapyN/A
2020-04-11 17:45 ESTNewsGenprex down 17% on equity offeringN/A
2020-04-11 17:14 ESTNewsGenprex bolsters Board of Directors; shares up 13% premarketN/A
2020-04-05 04:43 ESTFinancialsCompany financials have been released.Neutral
2020-04-03 00:50 ESTFinancialsCompany financials have been released.Neutral
2020-03-22 00:47 ESTFinancialsCompany financials have been released.Neutral

About Genprex, Inc (GNPX):

Genprex, Inc. operates as a clinical-stage gene therapy company that develops therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes. It develops drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company's lead product candidate REQORSA (quaratusugene ozeplasmid) for treatment for non-small cell lung cancer (NSCLC) has a multimodal mechanism of action to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis and programmed cell death in cancer cells; modulate immune response against cancer cells; and block mechanisms that create drug resistance. Genprex, Inc. was founded in 2009 and is headquartered in Austin, Texas.

See Advanced Chart

General

  • Name Genprex, Inc
  • Symbol GNPX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 8
  • Fiscal Year EndDecember
  • IPO Date2018-03-29
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.genprex.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 9.95
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.28
  • Return on Assets -69%
  • Return on Equity -114%
  • Earnings Per Share -$0.76
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 218.98 million
  • EBITDA -11505661
  • Analyst Target Price $6.67
  • Book Value Per Share $0.58
View More

Share Statistics

  • Shares Outstanding 43.28 million
  • Shares Float 30.84 million
  • % Held by Insiders 1755%
  • % Held by Institutions 23.37%
  • Shares Short 3.18 million
  • Shares Short Prior Month 3.27 million
  • Short Ratio 1.5
  • Short % of Float 8%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta -0.74
  • 52 Week High $7.72
  • 52 Week Low $1.95
  • 50 Day Moving Average 5.6
  • 200 Day Moving Average 4.11
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Genprex, Inc (GNPX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Genprex, Inc (GNPX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-12$N/A-$0.07-$0.2166.67%
2020-06-302020-08-11$N/A-$0.12-$0.1936.84%
2020-03-312020-05-14$N/A-$0.20-$0.08-150%
2019-09-302019-11-14$N/A-$0.15
2019-06-302019-08-13$N/A-$0.24-$0.21-14.29%
2019-03-312019-04-01$N/A-$0.23-$0.12-91.67%
2018-12-312019-03-29$N/A-$0.23-$0.13-76.92%
2018-09-302018-11-14$N/A-$0.15-$0.13-15.38%
2018-06-302018-08-14$N/A-$0.45
2018-03-312018-05-15$N/A-$0.06

Genprex, Inc (GNPX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Genprex, Inc (GNPX) Chart:

Genprex, Inc (GNPX) News:

Below you will find a list of latest news for Genprex, Inc (GNPX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Genprex, Inc (GNPX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-06-212.50.02CALL116 12710FALSE00
2024-06-2150CALL0 00FALSE00
2024-06-217.50.02CALL0 90FALSE00
2024-06-212.52.2PUT0 00TRUE00
2024-06-2150PUT0 00TRUE00
2024-06-217.50PUT0 00TRUE00
2024-09-202.50CALL0 1760FALSE00
2024-09-2050CALL0 00FALSE00
2024-09-207.50CALL0 10FALSE00
2024-09-202.50PUT0 00TRUE00
2024-09-2050PUT0 00TRUE00
2024-09-207.50PUT0 00TRUE00

Latest GNPX Trades:

Date Shares Price
Jun 13, 2022 7:41 PM EST5$1.325
Jun 13, 2022 7:47 PM EST5$1.33
Jun 13, 2022 7:57 PM EST5$1.325
Jun 13, 2022 7:59 PM EST94$1.325
Jun 13, 2022 7:59 PM EST100$1.325

Genprex, Inc (GNPX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-01S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1595248/000143774920014368/0001437749-20-014368-index.htm
2018-06-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1595248/000000000018018271/0000000000-18-018271-index.htm
2018-06-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1595248/000000000018020008/0000000000-18-020008-index.htm
2019-09-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1595248/000000000019013671/0000000000-19-013671-index.htm
2019-09-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1595248/000000000019013844/0000000000-19-013844-index.htm
2019-10-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1595248/000000000019014539/0000000000-19-014539-index.htm
2019-10-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1595248/000000000019014766/0000000000-19-014766-index.htm
2020-06-29UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1595248/000000000020005780/0000000000-20-005780-index.htm
2020-01-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595248/000110465920009164/0001104659-20-009164-index.htm
2018-04-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595248/000117634718000005/0001176347-18-000005-index.htm
2018-03-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000118518518000535/0001185185-18-000535-index.htm
2018-03-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000118518518000537/0001185185-18-000537-index.htm
2018-03-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000118518518000539/0001185185-18-000539-index.htm
2018-03-293Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000118518518000541/0001185185-18-000541-index.htm
2018-04-03NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/1595248/000118518518000605/0001185185-18-000605-index.htm
2018-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000118518518000616/0001185185-18-000616-index.htm
2018-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000118518518000638/0001185185-18-000638-index.htm
2018-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000118518518000640/0001185185-18-000640-index.htm
2018-04-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000118518518000642/0001185185-18-000642-index.htm
2018-04-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000118518518000666/0001185185-18-000666-index.htm
2018-04-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000118518518000675/0001185185-18-000675-index.htm
2018-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000118518518000703/0001185185-18-000703-index.htm
2018-05-23DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000118518518000990/0001185185-18-000990-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000118518518001002/0001185185-18-001002-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000118518518001004/0001185185-18-001004-index.htm
2018-05-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000118518518001016/0001185185-18-001016-index.htm
2018-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000118518518001311/0001185185-18-001311-index.htm
2018-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000118518518001335/0001185185-18-001335-index.htm
2018-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000118518518001784/0001185185-18-001784-index.htm
2018-03-29POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1595248/000119312518101595/0001193125-18-101595-index.htm
2018-03-29424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1595248/000119312518101608/0001193125-18-101608-index.htm
2018-05-22S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1595248/000119312518169788/0001193125-18-169788-index.htm
2018-06-15S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1595248/000119312518194621/0001193125-18-194621-index.htm
2018-06-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1595248/000119312518194630/0001193125-18-194630-index.htm
2018-07-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1595248/000119312518217585/0001193125-18-217585-index.htm
2018-07-26S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1595248/000119312518226312/0001193125-18-226312-index.htm
2018-07-26CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1595248/000119312518226683/0001193125-18-226683-index.htm
2018-07-27424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1595248/000119312518228790/0001193125-18-228790-index.htm
2018-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000120919118057448/0001209191-18-057448-index.htm
2018-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000120919118057451/0001209191-18-057451-index.htm
2018-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000120919118057453/0001209191-18-057453-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000120919119005723/0001209191-19-005723-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000120919119005726/0001209191-19-005726-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000120919119005728/0001209191-19-005728-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000120919119007169/0001209191-19-007169-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000120919119007170/0001209191-19-007170-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000120919119007171/0001209191-19-007171-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000120919119010187/0001209191-19-010187-index.htm
2019-02-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000120919119011942/0001209191-19-011942-index.htm
2020-01-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595248/000121390020002192/0001213900-20-002192-index.htm
2019-02-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595248/000139382519000062/0001393825-19-000062-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595248/000139382520000044/0001393825-20-000044-index.htm
2019-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774919011776/0001437749-19-011776-index.htm
2019-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595248/000143774919016579/0001437749-19-016579-index.htm
2019-08-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774919017680/0001437749-19-017680-index.htm
2019-09-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774919018060/0001437749-19-018060-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774919018363/0001437749-19-018363-index.htm
2019-09-16S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1595248/000143774919018431/0001437749-19-018431-index.htm
2019-09-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1595248/000143774919019207/0001437749-19-019207-index.htm
2019-10-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1595248/000143774919019705/0001437749-19-019705-index.htm
2019-10-04S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1595248/000143774919019711/0001437749-19-019711-index.htm
2019-10-1610-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1595248/000143774919020136/0001437749-19-020136-index.htm
2019-10-1610-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595248/000143774919020137/0001437749-19-020137-index.htm
2019-10-1610-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595248/000143774919020138/0001437749-19-020138-index.htm
2019-10-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1595248/000143774919020140/0001437749-19-020140-index.htm
2019-10-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1595248/000143774919020555/0001437749-19-020555-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595248/000143774919022847/0001437749-19-022847-index.htm
2019-11-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1595248/000143774919023350/0001437749-19-023350-index.htm
2019-11-22DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774919023449/0001437749-19-023449-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774919023451/0001437749-19-023451-index.htm
2019-12-10PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1595248/000143774919024155/0001437749-19-024155-index.htm
2019-12-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1595248/000143774919024774/0001437749-19-024774-index.htm
2019-12-27S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1595248/000143774919024961/0001437749-19-024961-index.htm
2019-12-27S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1595248/000143774919024966/0001437749-19-024966-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920000026/0001437749-20-000026-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920000028/0001437749-20-000028-index.htm
2020-01-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920000215/0001437749-20-000215-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920000370/0001437749-20-000370-index.htm
2020-01-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920000815/0001437749-20-000815-index.htm
2020-01-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1595248/000143774920000816/0001437749-20-000816-index.htm
2020-01-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920000861/0001437749-20-000861-index.htm
2020-01-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1595248/000143774920001161/0001437749-20-001161-index.htm
2020-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920001173/0001437749-20-001173-index.htm
2020-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920001434/0001437749-20-001434-index.htm
2020-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920001745/0001437749-20-001745-index.htm
2020-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920001747/0001437749-20-001747-index.htm
2020-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920001850/0001437749-20-001850-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920002761/0001437749-20-002761-index.htm
2020-02-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920002863/0001437749-20-002863-index.htm
2020-02-19SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920002955/0001437749-20-002955-index.htm
2020-02-19S-3MEFRegistration adding securities to prior Form S-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1595248/000143774920002966/0001437749-20-002966-index.htm
2020-02-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1595248/000143774920003048/0001437749-20-003048-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920003170/0001437749-20-003170-index.htm
2020-03-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920005372/0001437749-20-005372-index.htm
2020-03-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920005374/0001437749-20-005374-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920005577/0001437749-20-005577-index.htm
2020-03-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920005799/0001437749-20-005799-index.htm
2020-03-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920005800/0001437749-20-005800-index.htm
2020-03-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920005801/0001437749-20-005801-index.htm
2020-03-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920005803/0001437749-20-005803-index.htm
2020-03-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920005893/0001437749-20-005893-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920005979/0001437749-20-005979-index.htm
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1595248/000143774920006522/0001437749-20-006522-index.htm
2020-03-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920006651/0001437749-20-006651-index.htm
2020-03-313/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920006665/0001437749-20-006665-index.htm
2020-03-313Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920006671/0001437749-20-006671-index.htm
2020-04-02S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920006794/0001437749-20-006794-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920008132/0001437749-20-008132-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920008700/0001437749-20-008700-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920008761/0001437749-20-008761-index.htm
2020-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1595248/000143774920008880/0001437749-20-008880-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920009269/0001437749-20-009269-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920010072/0001437749-20-010072-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595248/000143774920010758/0001437749-20-010758-index.htm
2020-05-15S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1595248/000143774920011012/0001437749-20-011012-index.htm
2020-05-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1595248/000143774920011163/0001437749-20-011163-index.htm
2020-05-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1595248/000143774920011503/0001437749-20-011503-index.htm
2020-05-21424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1595248/000143774920011504/0001437749-20-011504-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920011936/0001437749-20-011936-index.htm
2020-06-12S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1595248/000143774920013030/0001437749-20-013030-index.htm
2020-06-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920013198/0001437749-20-013198-index.htm
2020-06-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920013663/0001437749-20-013663-index.htm
2020-07-01CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1595248/000143774920014363/0001437749-20-014363-index.htm
2020-07-01S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1595248/000143774920014368/0001437749-20-014368-index.htm
2020-07-15CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1595248/000143774920015203/0001437749-20-015203-index.htm
2020-07-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920015874/0001437749-20-015874-index.htm
2020-07-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920015875/0001437749-20-015875-index.htm
2020-07-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920015876/0001437749-20-015876-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920016227/0001437749-20-016227-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595248/000143774920017533/0001437749-20-017533-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920017912/0001437749-20-017912-index.htm
2020-08-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920018691/0001437749-20-018691-index.htm
2020-08-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1595248/000143774920018692/0001437749-20-018692-index.htm
2020-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920018838/0001437749-20-018838-index.htm
2020-09-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920020392/0001437749-20-020392-index.htm
2020-10-02RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1595248/000143774920020677/0001437749-20-020677-index.htm
2019-11-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595248/000153561019000104/0001535610-19-000104-index.htm
2020-01-15SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595248/000153561020000039/0001535610-20-000039-index.htm
2020-01-23SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595248/000153561020000058/0001535610-20-000058-index.htm
2018-04-1710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1595248/000156459018008342/0001564590-18-008342-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000156459018013042/0001564590-18-013042-index.htm
2018-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595248/000156459018013661/0001564590-18-013661-index.htm
2018-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000156459018019446/0001564590-18-019446-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595248/000156459018021749/0001564590-18-021749-index.htm
2018-08-16PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1595248/000156459018021846/0001564590-18-021846-index.htm
2018-08-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1595248/000156459018022451/0001564590-18-022451-index.htm
2018-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000156459018024018/0001564590-18-024018-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000156459018028631/0001564590-18-028631-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595248/000156459018029612/0001564590-18-029612-index.htm
2018-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000156459018031311/0001564590-18-031311-index.htm
2019-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000156459019001517/0001564590-19-001517-index.htm
2019-02-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595248/000156459019003036/0001564590-19-003036-index.htm
2019-02-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595248/000156459019003037/0001564590-19-003037-index.htm
2019-02-15SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1595248/000156459019003043/0001564590-19-003043-index.htm
2019-02-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1595248/000156459019003096/0001564590-19-003096-index.htm
2019-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1595248/000156459019003163/0001564590-19-003163-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1595248/000156459019010279/0001564590-19-010279-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1595248/000156459019013900/0001564590-19-013900-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595248/000156459019019363/0001564590-19-019363-index.htm
2019-05-16NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1595248/000156459019019498/0001564590-19-019498-index.htm
2019-05-2010-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1595248/000156459019019788/0001564590-19-019788-index.htm
2018-07-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1595248/999999999518001895/9999999995-18-001895-index.htm
2019-10-28EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1595248/999999999519002409/9999999995-19-002409-index.htm
2020-05-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1595248/999999999520001210/9999999995-20-001210-index.htm
2020-07-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1595248/999999999520001843/9999999995-20-001843-index.htm

Genprex, Inc (GNPX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genprex, Inc (GNPX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1755%
Institutional Ownership: 2337%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-03-29JACK A ROTH10% Share HolderBuy40,000.005.00200,000.001,338,999.00https://www.sec.gov/Archives/edgar/data/1595248/000118518518000640/0001185185-18-000640-index.htm
2019-09-05John Rodney VarnerChief Executive OfficerBuy1,800.000.891,594.621,800.00https://www.sec.gov/Archives/edgar/data/1595248/000143774919018060/0001437749-19-018060-index.htm
2018-07-30Julien L PhamPresident & COOBuy500.003.401,700.00500.00https://www.sec.gov/Archives/edgar/data/1595248/000118518518001335/0001185185-18-001335-index.htm
2018-03-29Christy M. Nance10% Share HolderBuy50,000.005.00250,000.0050,000.00https://www.sec.gov/Archives/edgar/data/1595248/000118518518000638/0001185185-18-000638-index.htm
2018-03-29John Rodney VarnerChief Executive OfficerBuy10,000.005.0050,000.00544,735.00https://www.sec.gov/Archives/edgar/data/1595248/000118518518000642/0001185185-18-000642-index.htm